Artimplant reports net revenue of SEK 5.4 million for January - March, 2011

Editorial Checklist Reviewed
Artimplant ABMay 4 2011NewsGuard 100/100 Score

Artimplant AB (STO:ARTIB):

January 1 - March 31, 2011:

  • Net revenue amounted to SEK 5.4 million (4.8).
  • The net loss totaled SEK 3.9 million (4.7).
  • Earnings per stock unit amounted to SEK -0.03 (-0.08).
  • Artimplant's own sales as a proportion of total sales continued to increase and were equivalent to 73% (51) of product sales.
  • The launch of complementary Artelon® Tissue Reinforcement products has commenced in the USA.
  • A new product for the treatment of osteoarthritis in the thumb base joint has been cleared for sale in Europe.
  • A new CFO - Kjell Thörnbring has been recruited and he has taken up his position.
Source:

Artimplant AB

Posted in: Business / Finance

Tags: ,

Comments (0)

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback